HBV Infection | Resolved Infection | Vaccine immunity | Susceptibility | p | |
---|---|---|---|---|---|
n(%) | n(%) | n(%) | n(%) | ||
Overall | 38 (9.6) | 171 (43.3) | 81 (20.5) | 105 (26.6) | |
Gender | |||||
Female | 22 (9.4) | 94 (40.2) | 55 (23.5) | 63 (26.9) | 0.23 |
Male | 16 (10.0) | 77 (48.1) | 25 (15.6) | 42 (26.3) | |
Age group (years) | |||||
0–15 | 9 (11.1) | 2 (2.5) | 27 (33.3) | 43 (53.1) | < 0.01 |
16–30 | 14 (10.0) | 38 (27.2) | 36 (25.7) | 52 (37.1) | |
31–45 | 7 (8.0) | 68 (78.2) | 9 (10.3) | 3 (3.5) | |
+45 | 8 (9.6) | 62 (74.7) | 7 (8.4) | 6 (7.2) | |
Year of Birth | |||||
After 1995 | 19 (10.4) | 17 (9.3) | 58 (31.7) | 89 (48.6) | < 0.01 |
Before 1995 | 19 (9.1) | 153 (73.6) | 21 (10.1) | 15 (7.2) | |
Risk Factor | |||||
Piercing | 37 (9.9) | 169 (45.1) | 74 (19.7) | 95 (25.3) | 0.05 |
Tattoo | 23 (8.8) | 116 (44.6) | 55 (21.2) | 66 (25.4) | 0.52 |
Contact/miners | 18 (13.2) | 61 (44.9) | 21 (15.4) | 36 (26.5) | 0.18 |